Results 211 to 220 of about 20,228 (237)

Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. [PDF]

Proc Natl Acad Sci U S A
Jimmidi R, Monsivais D, Ta HM, Sharma KL, Bohren KM, Chamakuri S, Liao Z, Li F, Hakenjos JM, Li JY, Mishina Y, Pan H, Qin X, Robers MB, Sankaran B, Tan Z, Tang S, Vasquez YM, Wilkinson J, Young DW, Palmer SS, MacKenzie KR, Kim C, Matzuk MM.   +23 more
europepmc   +1 more source

Activin-A Regulates Bone Morphogenetic Protein Signaling in Pulmonary Endothelial Cells Without Affecting Bone Morphogenetic Protein Type-II Receptor Expression. [PDF]

Pulm Circ
Dunmore BJ, Kikuchi N, Li W, Upton PD, Morrell NW.   +4 more
europepmc   +1 more source

Sotatercept for pulmonary arterial hypertension on background therapy: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Proc (Bayl Univ Med Cent)
Manasrah A, Shehada W, Saad Rakab M, Naamani AER, Nazir A, Alqudah M, Khan F, Patel K, Tanashat M.   +8 more
europepmc   +1 more source

Efficacy of Expanded Hemodialysis and Comparison with Standard Hemodialysis and Online Hemodiafiltration. [PDF]

Int J Mol Sci
Bratsiakou A, Papasotiriou M, Davoulou P, Georgopoulou GA, Papachristou E, Goumenos DS.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Evolving roles of activins and inhibins in ovarian cancer pathophysiology.

American Journal of Physiology - Cell Physiology, 2023
Activins and Inhibins are unique members of the Transforming Growth Factor-b (TGFb) family of growth factors, with the ability to exert autocrine, endocrine, and paracrine effects in a wide range of complex physiologic and pathologic processes.
Elizabeth T. Evans, Ben Horst, R. Arend, Karthikeyan Mythreye   +3 more
semanticscholar   +1 more source